Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Nature Reviews. Clinical Oncology|September 30, 2009
Src kinases as therapeutic targets for cancerLori C Kim, Lanxi Song, Eric B Haura
Molecular Cancer Therapeutics|January 11, 2011
JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signalingLanxi Song, Bhupendra Rawal, Jeffrey A Nemeth, et al.
Cancer Biology & Therapy|March 9, 2005
Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cellsLanxi Song, Domenico Coppola, Sandy Livingston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancerEric B Haura, Zhong Zheng, Lanxi Song, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 14, 2007
Effects of IFN-gamma and Stat1 on gene expression, growth, and survival in non-small cell lung cancer cellsJiannong Li, Bin Yu, Lanxi Song, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2010
A pilot study of preoperative gefitinib for early-stage lung cancer to assess intratumor drug concentration and pathways mediating primary resistanceEric B Haura, Eric Sommers, Lanxi Song, et al.
Oncogene|February 22, 2002
Direct repression of the Mcl-1 promoter by E2F1Rhonda Croxton, Yihong Ma, Lanxi Song, et al.
Pageof 2